메뉴 건너뛰기
Leukemia and Lymphoma
Volumn 53, Issue 8, 2012, Pages 1617-1619
Risk factors associated with Clostridium difficile infection in adult oncology patients with a history of recent hospitalization for febrile neutropenia
Author keywords

[No Author keywords available]
Indexed keywords

AZITHROMYCIN; AZTREONAM; CARBAPENEM; CEFEPIME; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;
EID: 84864238154     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.654472     Document Type: Letter
Times cited : (26)
References (18)
  • 1
    • 80053253206 scopus 로고    scopus 로고
    • Biology of clostridium difficile: Implications for epidemiology and diagnosis
    • K aren CC, John GB. Biology of Clostridium diffi cile: implications for epidemiology and diagnosis. Annu Rev Microbiol 2011;65:501-521.
    • (2011) Annu. Rev. Microbiol. , vol.65 , pp. 501-521
    • Karen, C.C.1    John, G.B.2
  • 2
    • 79960237645 scopus 로고    scopus 로고
    • Epidemiology and control of clostridium difficile infections in healthcare settings: An update
    • B arbut F, Jones G, Eckert C. Epidemiology and control of Clostridium diffi cile infections in healthcare settings: an update. Curr Opin Infect Dis 2011;24:370-376.
    • (2011) Curr. Opin. Infect Dis. , vol.24 , pp. 370-376
    • Barbut, F.1    Jones, G.2    Eckert, C.3
  • 3
    • 23044492161 scopus 로고    scopus 로고
    • Effect of antibiotic treatment on growth of and toxin production by clostridium difficile in the cecal contents of mice
    • Pultz NJ, Donskey CJ. Eff ect of antibiotic treatment on growth of and toxin production by Clostridium diffi cile in the cecal contents of mice. Antimicrob Agents Chemother 2005;49:3529-3532.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 3529-3532
    • Pultz, N.J.1    Donskey, C.J.2
  • 4
    • 79951816939 scopus 로고    scopus 로고
    • Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer 2010 update by the infectious diseases society of america
    • Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:e56-e93.
    • (2011) Clin. Infect Dis. , vol.52
    • Freifeld, A.G.1    Bow, E.J.2    Sepkowitz, K.A.3
  • 5
    • 79960976033 scopus 로고    scopus 로고
    • A call to arms: The imperative for antimicrobial stewardship
    • B artlett JG. A call to arms: the imperative for antimicrobial stewardship. Clin Infect Dis 2011;53(Suppl. 1):S4-S7.
    • (2011) Clin. Infect Dis. , vol.53 , Issue.1
    • Bartlett, J.G.1
  • 6
    • 33846153776 scopus 로고    scopus 로고
    • Infectious diseases society of america and the society for healthcare epidemiology of america guidelines for developing an institutional program to enhance antimicrobial stewardship
    • Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159-177.
    • (2007) Clin. Infect Dis. , vol.44 , pp. 159-177
    • Dellit, T.H.1    Owens, R.C.2    McGowan Jr., J.E.3
  • 7
    • 0023873753 scopus 로고
    • Clostridium difficile infection in patients with haematological malignant disease risk factors faecal toxins and pathogenic strains
    • Heard SR, Wren B, Barnett MJ, et al. Clostridium diffi cile infection in patients with haematological malignant disease. Risk factors, faecal toxins and pathogenic strains. Epidemiol Infect 1988;100:63-72.
    • (1988) Epidemiol. Infect , vol.100 , pp. 63-72
    • Heard, S.R.1    Wren, B.2    Barnett, M.J.3
  • 8
    • 0021981980 scopus 로고
    • Clostridium difficile in haematological malignancy
    • R ampling A, Warren RE, Bevan PC, et al. Clostridium diffi cile in haematological malignancy. J Clin Pathol 1985;38:445-451.
    • (1985) J. Clin. Pathol. , vol.38 , pp. 445-451
    • Rampling, A.1    Warren, R.E.2    Bevan, P.C.3
  • 10
    • 85047690853 scopus 로고
    • Clostridiumdifficile colonization and toxin production in a cohort of patients with malignant hematologic disorders
    • Morris JG Jr, Jarvis WR, Nunez-Montiel OL, et al. Clostridiumdiffi cile. Colonization and toxin production in a cohort of patients with malignant hematologic disorders. Arch Intern Med 1984;144: 967-969.
    • (1984) Arch. Intern. Med. , vol.144 , pp. 967-969
    • Morris Jr., J.G.1    Jarvis, W.R.2    Nunez-Montiel, O.L.3
  • 11
    • 7144259741 scopus 로고    scopus 로고
    • Determination and validation of a predictive model for clostridium difficile diarrhea in hospitalized oncology patients
    • Hornbuckle K, Chak A, Lazarus HM, et al. Determination and validation of a predictive model for Clostridium diffi cile diarrhea in hospitalized oncology patients. Ann Oncol 1998;9:307-311.
    • (1998) Ann. Oncol. , vol.9 , pp. 307-311
    • Hornbuckle, K.1    Chak, A.2    Lazarus, H.M.3
  • 12
    • 80455173556 scopus 로고    scopus 로고
    • Host and pathogen factors for clostridium diffi cile infection and colonization
    • L oo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium diffi cile infection and colonization. N Engl J Med 2011;365:1693-1703.
    • (2011) N. Engl. J. Med. , vol.365 , pp. 1693-1703
    • Loo, V.1    Bourgault, A.M.2    Poirier, L.3
  • 13
    • 79952066185 scopus 로고    scopus 로고
    • Anti-pseudomonal beta-lactams for the initial empirical treatment of febrile neutropenia: Comparison of beta-lactams
    • Paul M, Yahav D, Bivas A, et al. Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. Cochrane Database Syst Rev 2010;(11):CD005197.
    • (2010) Cochrane Database Syst. Rev. , vol.11
    • Paul, M.1    Yahav, D.2    Bivas, A.3
  • 14
    • 33748687964 scopus 로고    scopus 로고
    • Moxifl oxacin prophylaxis in neutropenic patients
    • v on Baum H, Sigge A, Bommer M, et al. Moxifl oxacin prophylaxis in neutropenic patients. J Antimicrob Chemother 2006;58:891-894.
    • (2006) J. Antimicrob Chemother , vol.58 , pp. 891-894
    • Von Baum, H.1    Sigge, A.2    Bommer, M.3
  • 15
    • 79251554095 scopus 로고    scopus 로고
    • Use of antibacterial prophylaxis for patients with neutropenia australian consensus guidelines 2011 steering committee
    • S lavin MA, Lingaratnam S, Mileshkin L, et al. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee. Intern Med J 2011;41:102-109.
    • Intern. Med. J. , vol.2011 , Issue.41 , pp. 102-109
    • Slavin, M.A.1    Lingaratnam, S.2    Mileshkin, L.3
  • 16
    • 80054075999 scopus 로고    scopus 로고
    • Comparison of five assays for detection of clostridium difficile toxin
    • Chapin KC, Dickenson RA, Wu F, et al. Comparison of fi ve assays for detection of Clostridium diffi cile toxin. J Mol Diagn 2011;13: 395-400.
    • (2011) J. Mol. Diagn. , vol.13 , pp. 395-400
    • Chapin, K.C.1    Dickenson, R.A.2    Wu, F.3
  • 17
    • 71349084101 scopus 로고    scopus 로고
    • Clostridium difficile-associated diarrhoea a frequent complication in patients with acute myeloid leukaemia
    • Schalk E, Bohr UR, Konig B, et al. Clostridium diffi cile-associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia. Ann Hematol 2009;89:9-14.
    • (2009) Ann. Hematol. , vol.89 , pp. 9-14
    • Schalk, E.1    Bohr, U.R.2    Konig, B.3
  • 18
    • 0035884759 scopus 로고    scopus 로고
    • Clostridium difficile infection in patients with neutropenia
    • G orschluter M, Glasmacher A, Hahn C, et al. Clostridium diffi cile infection in patients with neutropenia. Clin Infect Dis 2001;33: 786-791.
    • (2001) Clin. Infect Dis. , vol.33 , pp. 786-791
    • Gorschluter, M.1    Glasmacher, A.2    Hahn, C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.